US Patent No: 7,344,705

Number of patents in Portfolio can not be more than 2000

Composition comprising low density microspheres

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Low density microspheres, methods for preparing same, and use of same as contrast agents are described. The microspheres have a void which contains a gas or the vapor of a volatile liquid selected from the group consisting of aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes and perfluorocarbons.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
LANTHEUS MEDICAL IMAGING, INC.NEW YORK, NY69

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Unger, Evan C Tucson, AZ 153 8019

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (5)
4,822,534 Method of producing microspheres 100 1987
4,996,041 Method for introducing oxygen-17 into tissue for imaging in a magnetic resonance imaging system 106 1988
5,190,766 Method of controlling drug release by resonant sound wave 205 1991
5,315,998 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same 191 1992
5,339,814 Process for visualizing tissue metabolism using oxygen-17 53 1992
 
MINNESOTA MINING AND MANUFACTURING COMPANY (3)
5,785,950 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them 25 1994
5,502,094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use 80 1995
5,567,765 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use 95 1996
 
BERSTEIN, ROBERT L. (1)
4,663,161 Liposome methods and compositions 112 1985
 
BRACCO INTERNATIONAL B.V. (5)
5,711,933 Method of making polymeric gas or air filled microballoons for ultrasonic echography 118 1994
5,531,980 Stable microbubbles suspensions injectable into living organisms 112 1994
5,578,292 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof 89 1995
5,567,414 Stable microbubbles suspensions injectable into living organisms 108 1995
5,643,553 Stable microbubbles suspensions injectable into living organisms 111 1995
 
Matsumoto Yushi-Seiyaku Co., Ltd. (1)
4,582,756 Organic microballoon 45 1984
 
RAMOT AT TEL-AVIV UNIVERSITY LTD. (1)
5,135,000 Method of measuring regional tissue blood flow 110 1991
 
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION (1)
6,635,017 Method and apparatus combining diagnostic ultrasound with therapeutic ultrasound to enhance thrombolysis 95 2000
 
DIOR PARFUMS CHRISTIAN, A COMPANY OF FRANCE (1)
4,621,023 Method of homogenizing dispersions of hydrated lipidic lamellar phases and suspensions obtained by the said method 50 1983
 
Royal Appliance Mfg. Co. (1)
5,535,500 Method for manufacturing a bucket for a wet/dry vacuum cleaner 37 1995
 
SYNTEX (U.S.A.) INC. (1)
5,470,582 Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles 106 1993
 
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (1)
5,612,318 Control of gene expression by ionizing radiation 48 1994
 
Eli Lilly and Company (1)
4,331,654 Magnetically-localizable, biodegradable lipid microspheres 312 1980
 
HemaGen/PFC (3)
5,350,571 Emulsions of highly fluorinated organic compounds 86 1992
5,571,498 Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI). 30 1994
5,635,539 Stable emulsions of highly fluorinated organic compounds 25 1996
 
HOECHST AKTIENGESELLSCHAFT (1)
5,205,287 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 245 1992
 
NATIONAL RESEARCH DEVELOPMENT CORPORATION (1)
4,427,649 Pharmaceutical compositions 97 1981
 
AECI LIMITED (1)
4,790,891 Process for the production of a cartridged explosive with entrapped bubbles 84 1987
 
ELAN PHARMACEUTICALS, INC. (2)
4,981,692 Therapeutic treatment by intramammary infusion 95 1987
5,008,050 Extrusion technique for producing unilamellar vesicles 174 1989
 
BRACCO SUISSE SA (7)
5,271,928 Stable microbubbles suspensions injectable into living organisms 191 1991
5,310,540 Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography 144 1992
5,380,519 Stable microbubbles suspensions injectable into living organisms 203 1993
5,445,813 Stable microbubble suspensions as enhancement agents for ultrasound echography 118 1993
5,556,610 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method 177 1994
5,686,060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography 79 1995
6,258,378 Delivery of biologically active substance to target sites in the body of patients 77 1999
 
Research Development Foundation (1)
5,049,388 Small particle aerosol liposome and liposome-drug combinations for medical use 200 1989
 
The Regents of the University of California (1)
4,767,610 Method for detecting abnormal cell masses in animals 42 1984
 
L'OREAL (1)
5,593,680 New cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded microspheres 94 1994
 
HEMAGEN/PFC, 655 MONTGOMERY STREET, SUITE 1710, SAN FRANCISCO, CA. 94111, A LIMITED PARTNERSHIP OF CA. (1)
5,171,755 Emulsions of highly fluorinated organic compounds 120 1988
 
THE UNIVERSITY OF BRITISH COLUMBIA (1)
5,283,255 Wavelength-specific cytotoxic agents 71 1992
 
The Board of Trustees of the University of Illinois (1)
5,858,399 Acoustically reflective liposomes and methods to make and use the same 46 1996
 
SCHLIEF, REINHARD (1)
5,195,520 Ultrasonic manometry process in a fluid by means of microbubbles 174 1991
 
NIPPON STEEL CORPORATION (1)
5,147,631 Porous inorganic ultrasound contrast agents 217 1991
 
Sequus Pharmaceuticals, Inc. (2)
5,213,804 Solid tumor treatment method and composition 228 1991
5,620,689 Liposomes for treatment of B-cell and T-cell disorders 97 1995
 
COLLABORATIVE RESEARCH, INC. (1)
4,342,826 Immunoassay products and methods 110 1981
 
CEREVAST THERAPEUTICS, INC. (6)
5,149,319 Methods for providing localized therapeutic heat to biological tissues and fluids 258 1990
5,558,092 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously 401 1995
5,770,222 Therapeutic drug delivery systems 222 1995
6,537,246 Oxygen delivery agents and uses for the same 61 1997
6,315,981 Gas filled microspheres as magnetic resonance imaging contrast agents 73 1999
6,444,660 Lipid soluble steroid prodrugs 14 2000
 
IMARX PHARMACEUTICAL (1)
6,461,586 Method of magnetic resonance focused surgical and therapeutic ultrasound 24 2000
 
BIOCOMPATIBLES UK LIMITED (1)
4,675,310 Liposome composition as gas transport agents 88 1985
 
STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (1)
4,863,717 Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging 125 1986
 
ATTA (1)
4,985,550 Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants 89 1987
 
OLSON, CAMILLA (1)
5,433,204 Method of assessing placentation 168 1993
 
Carlton Medical Products Limited (1)
4,646,756 Ultra sound hyperthermia device 200 1983
 
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (1)
4,938,947 Aerosol composition for in vivo imaging 85 1988
 
BARNES-JEWISH HOSPITAL (2)
5,958,371 Site specific binding system, nuclear imaging compositions and methods 38 1997
5,989,520 Site specific binding system, imaging compositions and methods 31 1998
 
Linton Medical Services Limited (1)
4,428,924 Preparation for diagnostic radiology 68 1980
 
PQ CORPORATION (4)
4,420,442 Manufacturing process for hollow microspheres 113 1982
4,421,562 Manufacturing process for hollow microspheres 99 1983
4,549,892 Process for producing hollow, bilayered silicate microspheres 68 1983
4,540,629 Hollow microspheres with organosilicon-silicate walls 84 1984
 
NORTHWESTERN UNIVERSITY (1)
5,612,057 Acoustically reflective liposomes and methods to make and use same 54 1995
 
SILICON VALLEY BANK (1)
5,193,183 System for accessing design data of modeler subsystems by reference to partnership set and for dynamically correlating design data of modeler subsystems 42 1990
 
IMARX THERAPEUTICS, INC. (7)
5,209,720 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes 184 1991
5,358,702 Methoxylated gel particle contrast media for improved diagnostic imaging 78 1993
5,736,121 Stabilized homogenous suspensions as computed tomography contrast agents 32 1995
5,874,062 Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents 38 1995
5,997,898 Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery 26 1995
6,414,139 Silicon amphiphilic compounds and the use thereof 27 1996
6,143,276 Methods for delivering bioactive agents to regions of elevated temperatures 76 1997
 
CAVITATION-CONTROL TECHNOLOGY, INC. (2)
4,684,479 Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures 205 1985
5,215,680 Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles 317 1990
 
University of Kentucky Research Foundation (1)
5,019,370 Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging 103 1989
 
SURFACTANT TECHNOLOGIES, INC. (2)
4,426,330 Synthetic phospholipid compounds 158 1981
4,534,899 Synthetic phospholipid compounds 191 1983
 
E.R. SQUIBB & SONS, INC. (1)
4,830,858 Spray-drying method for preparing liposomes and products produced thereby 146 1985
 
ALKERMES PHARMA IRELAND LIMITED (1)
5,569,448 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions 160 1995
 
AMERICAN BIOSCIENCE, INC. (1)
5,362,478 Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell 158 1993
 
CALFEE HALTER & GRISWOLD, LLP (1)
4,603,044 Hepatocyte Directed Vesicle delivery system 140 1984
 
WAYNE STATE UNIVERSITY (1)
5,045,304 Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same 74 1988
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
4,689,986 Variable frequency gas-bubble-manipulating apparatus and method 148 1985
 
HAFSTRUND NYCOMED INNOVATION, AB (1)
4,984,573 Method of electron spin resonance enhanced magnetic resonance imaging 72 1988
 
THE CURATORS OF THE UNIVERSITY OF MISSOURI (1)
4,789,501 Glass microspheres 169 1984
 
PNC BANK, NATIONAL ASSOCIATION (1)
4,533,254 Apparatus for forming emulsions 281 1984
 
The Lubrizol Corporation (1)
4,728,578 Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers 91 1986
 
PFC THERAPEUTICS, LLC (8)
4,865,836 Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport 158 1986
4,919,895 Apparatus for oxygenation of liquid state dissolved oxygen-carrying formulation 86 1987
4,987,154 Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use 138 1987
4,927,623 Dissolution of gas in a fluorocarbon liquid 168 1988
5,077,036 Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid 54 1990
4,993,415 Magnetic resonance imaging with perfluorocarbon hydrides 120 1990
5,344,930 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties 113 1993
5,679,459 Perfluorinated amphiphilic phosphorous compounds: liposomal compositions 55 1995
 
University of Massachusetts (2)
4,544,545 Liposomes containing modified cholesterol for organ targeting 459 1983
4,900,540 Lipisomes containing gas for ultrasound detection 246 1983
 
ALLIANCE PHARMACEUTICAL CORP. (2)
5,460,800 Labeled fluorocarbon compositions 37 1994
5,980,936 Multiple emulsions comprising a hydrophobic continuous phase 73 1997
 
Lancaster Group GmbH (1)
5,686,102 Pharmacological composition for topical administration 79 1996
 
GORDON, DAVID, SKOKIE, ILLINOIS (2)
4,569,836 Cancer treatment by intracellular hyperthermia 96 1983
4,731,239 Method for enhancing NMR imaging; and diagnostic use 123 1986
 
BASF AKTIENGESELLSCHAFT (1)
4,972,002 Process for producing cellular plastics by the polyisocyanate polyaddition method by means of stable emulsions containing blowing agents, and such emulsions 93 1989
 
NOVARTIS AG (1)
4,863,740 Interleukin therapy 30 1988
 
ACUSPHERE, INC. (2)
5,425,366 Ultrasonic contrast agents for color Doppler imaging 259 1993
6,068,857 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production 67 1996
 
LASERSONIX TECHNOLOGIES (1)
5,840,023 Optoacoustic imaging for medical diagnosis 237 1996
 
La Jolla Cancer Research Foundation (1)
5,672,585 Method and composition for treating thrombosis 58 1995
 
IMCOR PHARMACEUTICAL CO. (1)
5,496,535 Fluorocarbon contrast media for use with MRI and radiographic imaging 79 1991
 
HENKEL CORPORATION (1)
4,722,943 Composition and process for drying and expanding microspheres 66 1987
 
LIPOSOME TECHNOLOGY, INC. A CORP. OF DELAWARE (4)
4,737,323 Liposome extrusion method 229 1986
4,781,871 High-concentration liposome processing method 129 1986
4,895,719 Method and apparatus for administering dehydrated liposomes by inhalation 306 1987
5,013,556 Liposomes with enhanced circulation time 649 1989
 
KABUSHIKI KAISHA TOSHIBA (2)
4,620,546 Ultrasound hyperthermia apparatus 198 1985
5,485,839 Method and apparatus for ultrasonic wave medical treatment using computed tomography 127 1994
 
TRANSON LLC (2)
5,695,460 Enhancement of ultrasound thrombolysis 150 1995
6,682,502 Apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion 57 2001
 
SLF LIMITED PARTNERSHIP (3)
4,572,203 Contact agents for ultrasonic imaging 262 1983
4,718,433 Contrast agents for ultrasonic imaging 273 1985
4,774,958 Ultrasonic imaging agent and method of preparation 261 1987
 
TRANSAVE, INC. (1)
5,552,155 Fusogenic lipsomes and methods for making and using same 71 1994
 
CIBA CORNING DIAGNOSTICS CORP. (1)
4,933,121 Process for forming liposomes 89 1988
 
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (6)
5,567,415 Ultrasound contrast agents and methods for their manufacture and use 89 1994
5,560,364 Suspended ultra-sound induced microbubble cavitation imaging 152 1995
5,701,899 Perfluorobutane ultrasound contrast agent and methods for its manufacture and use 90 1995
5,648,098 Thrombolytic agents and methods of treatment for thrombosis 55 1995
5,849,727 Compositions and methods for altering the biodistribution of biological agents 56 1996
5,740,807 Suspended ultra-sound induced microbubble cavitation imaging 54 1996
 
LVMH RECHERCHE, A FRENCH CORP. (1)
5,198,225 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids 82 1991
 
SIEMENS AKTIENGESELLSCHAFT (1)
4,334,929 Use of nickel-cobalt sintered materials for electric relay contacts 3 1980
 
WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (1)
5,648,095 Preparation of microparticles 119 1994
 
FUJITSU LIMITED (1)
5,539,814 Method and apparatus for informing active subscriber of disconnection of held subscriber in call-waiting service 22 1995
 
NanoScan Imaging LLC (1)
5,114,703 Percutaneous lymphography using particulate fluorocarbon emulsions 148 1990
 
The Trustees of the University of Pennsylvania (1)
5,196,348 Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of biopsied tissue 61 1991
 
ABRAXIS BIOSCIENCE, LLC (5)
5,498,421 Composition useful for in vivo delivery of biologics and methods employing same 280 1994
5,508,021 Non-fluorinated polymeric shells for medical imaging 134 1994
5,505,932 Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging 149 1995
5,512,268 Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof 109 1995
5,639,473 Methods for the preparation of nucleic acids for in vivo delivery 118 1995
 
TAKEDA CHEMICAL INDUSTRIES, LTD. (1)
4,877,561 Method of producing liposome 93 1987
 
BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC. (1)
6,416,740 Acoustically active drug delivery systems 145 1998
 
AMERSHAM HEALTH AS (1)
5,897,851 Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging 32 1996
 
GE HEALTHCARE AS (22)
4,844,882 Concentrated stabilized microbubble-type ultrasonic imaging agent 247 1987
5,558,855 Phase shift colloids as ultrasound contrast agents 102 1993
5,393,524 Methods for selecting and using gases as ultrasound contrast media 166 1993
5,529,766 Contrast agents 102 1993
5,536,490 Contrast agents 116 1993
5,595,723 Method for preparing storage stable colloids 82 1993
5,558,853 Phase shift colloids as ultrasound contrast agents 144 1994
5,562,893 Gas-filled microspheres with fluorine-containing shells 88 1994
5,558,856 Microbubble-generating contrast agents for ultrasound and magnetic resonance imaging 145 1994
5,573,751 Persistent gaseous bubbles as ultrasound contrast media 79 1994
5,558,854 Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas 104 1995
5,558,094 Methods for using persistent gases as ultrasound contrast media 97 1995
5,614,169 Contrast agents, consisting of galactose particles and an amphilic carboxylic acid 63 1995
5,567,413 Flexible amphiphilic microbubbles for ultrasound 98 1995
5,676,928 Liposomes 93 1995
5,707,606 Phase shift colloids as ultrasound contrast agents 55 1995
5,707,607 Phase shift colloids as ultrasound contrast agents 61 1995
5,976,501 Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion 31 1996
6,331,289 Targeted diagnostic/therapeutic agents having more than one different vectors 71 1997
6,261,537 Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors 150 1997
6,159,445 Light imaging contrast agents 217 1997
6,680,047 Diagnostic/therapeutic agents 40 2001
 
The Penn State Research Foundation (1)
5,487,390 Gas-filled polymeric microbubbles for ultrasound imaging 151 1994
 
ISOTECHNIKA INC. (1)
5,846,514 Enhancement of the efficacy of nifedipine by deuteration 90 1996
 
ALZA CORPORATION (1)
4,344,929 Method of delivering drug with aid of effervescent activity generated in environment of use 119 1981
 
INSIGHTEC LTD. (1)
5,247,935 Magnetic resonance guided focussed ultrasound surgery 136 1992
 
DREWES, WILLIAM (1)
4,315,514 Method and apparatus for selective cell destruction 221 1980
 
THOMSON-CSF (1)
4,586,512 Device for localized heating of biological tissues 219 1985
 
NOVAVAX, INC. (2)
5,000,960 Protein coupling to lipid vesicles 100 1989
5,219,538 Gas and oxygen carrying lipid vesicles 88 1991
 
NYCOMED IMAGING AS (3)
5,196,183 Contrast agents for ultrasound imaging 114 1991
5,354,549 Iodinated esters 77 1991
5,569,449 Gaseous microparticles as ultrasound contrast agents 93 1995
 
CALIFORNIA INSTITUTE OF TECHNOLOGY (1)
4,310,506 Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species 145 1980
 
SCHERING AKTIENGESELLSCHAFT (7)
4,442,843 Microbubble precursors and methods for their production and use 239 1981
4,466,442 Carrier liquid solutions for the production of gas microbubbles, preparation thereof, and use thereof as contrast medium for ultrasonic diagnostics 301 1982
4,657,756 Microbubble precursors and apparatus for their production and use 258 1983
4,681,119 Method of production and use of microbubble precursors 224 1986
4,918,065 Corticoid-containing preparation for topical application 55 1988
5,141,738 Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof 181 1991
5,501,863 Contrast media synthesized from polyaldehydes 120 1995
 
THE DOW CHEMICAL COMPANY (1)
4,485,193 Expandable synthetic resinous thermoplastic particles, method for the preparation thereof and the application therefor 47 1984
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (4)
4,921,706 Unilamellar lipid vesicles and method for their formation 139 1984
4,898,734 Polymer composite for controlled release or membrane formation 207 1988
4,893,624 Diffuse focus ultrasound hyperthermia system 175 1988
5,565,215 Biodegradable injectable particles for imaging 141 1994
 
REINHARD SCHLIEF (1)
5,380,411 Ultrasound or shock wave work process and preparation for carrying out same 137 1990
 
TECHNOMED MEDICAL SYSTEMS (1)
4,658,828 Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment 165 1985
 
CEREVAST MEDICAL, INC. (2)
6,716,412 Methods of ultrasound treatment using gas or gaseous precursor-filled compositions 34 2001
6,576,220 Non-invasive methods for surgery in the vasculature 24 2001
 
TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (1)
5,562,608 Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation 236 1995
 
Patrinove (1)
5,194,188 Process and a device for the direct production of liposomes 19 1991
 
Exogen, Inc. (2)
4,530,360 Method for healing bone fractures with ultrasound 198 1982
5,556,372 Apparatus for ultrasonic bone treatment 118 1995
 
DR. F. KOHLER CHEMIE GMBH (2)
5,137,928 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 179 1991
5,190,982 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 115 1992
 
MALLINCKRODT MEDICAL, INC. (1)
5,362,477 19F magnetic resonance imaging agents which include a nitroxide moiety 51 1992
 
Aktiebolaget Draco (1)
4,693,999 Liposomes containing steroid esters 72 1985
 
SUMMERS, DAVID (1)
5,186,922 Use of biodegradable microspheres labeled with imaging energy constrast materials 125 1990
 
Molecular Biosystems, Inc. (9)
4,957,656 Continuous sonication method for preparing protein encapsulated microbubbles 227 1988
5,107,842 Method of ultrasound imaging of the gastrointestinal tract 96 1991
5,315,997 Method of magnetic resonance imaging using diamagnetic contrast 135 1992
5,716,597 Emulsions as contrast agents and method of use 65 1993
5,552,133 Method of making encapsulated gas microspheres useful as an ultrasonic imaging agent 143 1994
5,536,489 Emulsions as contrast agents and method of use 149 1995
5,606,973 Liquid core microdroplets for ultrasound imaging 66 1995
5,732,707 Method of ultrasonically quantitating myocardial perfusion using as intravenously injected tracer 113 1996
5,855,865 Method for making encapsulated gas microspheres from heat denatured protein in the absence of oxygen gas 60 1997
 
ILLINOIS INSTITUTE OF TECHNOLOGY, A NOT-FOR-PROFIT CORP. OF ILLINOIS (1)
4,776,991 Scaled-up production of liposome-encapsulated hemoglobin 125 1986
 
CHILDREN'S HOSPITAL RESEARCH FOUNDATION (2)
4,775,522 NMR compositions for indirectly detecting a dissolved gas in an animal 116 1985
5,536,753 Stable perfluorocarbon and oil emulsions 18 1990
 
The Research Foundation of State University of New York (1)
5,545,396 Magnetic resonance imaging using hyperpolarized noble gases 129 1994
 
NEXSTAR PHARMACEUTICALS, INC. (2)
4,728,575 Contrast agents for NMR imaging 122 1985
5,008,109 Vesicle stabilization 82 1988
 
DANA-FARBER CANCER INSTITUTE, INC. (1)
5,571,797 Method of inducing gene expression by ionizing radiation 52 1994
 
TARGESON, INC. (6)
5,605,673 Stabilized microbubble compositions for ultrasound 112 1994
5,540,909 Harmonic ultrasound imaging with microbubbles 146 1994
5,639,443 Stabilized microbubble compositions 113 1995
5,626,833 Ultrasound imaging method using microbubbles 70 1995
5,804,162 Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients 54 1995
5,733,527 Methods for harmonic imaging with ultrasound 65 1996
 
LIPSOME TECHNOLOGY, INC. (1)
5,194,266 Amphotericin B/cholesterol sulfate composition and method 77 1991
 
EASTMAN KODAK COMPANY (1)
5,078,994 Microgel drug delivery system 99 1990
 
M.R.I., Inc. (1)
4,834,964 Use of charged nitroxides as NMR image enhancing agents for CSF 81 1986
 
AIR PRODUCTS AND CHEMICALS, INC. (2)
4,866,096 Stable fluorochemical aqueous emulsions 70 1987
4,895,876 Concentrated stable fluorochemical aqueous emulsions containing triglycerides 63 1987
 
LANTHEUS MEDICAL IMAGING, INC. (24)
5,088,499 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 216 1990
5,205,290 Low density microspheres and their use as contrast agents for computed tomography 121 1991
5,228,446 Gas filled liposomes and their use as ultrasonic contrast agents 97 1991
5,123,414 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 168 1991
5,230,882 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 107 1992
5,352,435 Ionophore containing liposomes for ultrasound imaging 122 1992
5,281,408 Low density microspheres and their use as contrast agents for computed tomography 170 1993
5,305,757 Gas filled liposomes and their use as ultrasonic contrast agents 96 1993
5,469,854 Methods of preparing gas-filled liposomes 232 1993
5,334,381 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 205 1993
5,456,900 Low density microspheres and their use as contrast agents for computed tomography 69 1993
5,542,935 Therapeutic delivery systems related applications 290 1993
5,585,112 Method of preparing gas and gaseous precursor-filled microspheres 221 1993
5,830,430 Cationic lipids and the use thereof 112 1995
5,547,656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications 152 1995
5,527,521 Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications 94 1995
6,146,657 Gas-filled lipid spheres for use in diagnostic and therapeutic applications 60 1996
5,846,517 Methods for diagnostic imaging using a renal contrast agent and a vasodilator 129 1997
6,528,039 Low density microspheres and their use as contrast agents for computed tomography and in other applications 36 1997
6,548,047 Thermal preactivation of gaseous precursor filled compositions 66 1997
6,231,834 Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same 98 1997
6,551,576 Container with multi-phase composition for use in diagnostic and therapeutic applications 55 1998
6,056,938 Cationic lipids and the use thereof 53 1998
6,479,034 Method of preparing gas and gaseous precursor-filled microspheres 33 1998
 
PHARES PHARMACEUTICAL RESEARCH, N.V. (1)
5,004,611 Pro-liposome compositions 95 1988
 
VANDERBILT UNIVERSITY (1)
4,615,879 Particulate NMR contrast agents for gastrointestinal application 138 1983
 
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (2)
5,192,549 Method of amphiphatic drug loading in liposomes by pH gradient 138 1989
5,316,771 Method of amphiphatic drug loading in liposomes by ammonium ion gradient 142 1992
 
DUPONT PHARMACEUTICALS COMPANY (2)
6,443,898 Therapeutic delivery systems 63 1995
6,521,211 Methods of imaging and treatment with targeted compositions 99 1999
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
DIXIE CONSUMER PRODUCTS LLC (1)
* 2010/0012,712 PAPER CUP MANUFACTURE WITH MICROENCAPSULATED ADHESIVE 2 2009
 
WELLS FARGO BANK, NATIONAL ASSOCIATION (2)
8,685,441 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 0 2013
8,747,892 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 0 2013
 
LANTHEUS MEDICAL IMAGING, INC. (3)
8,084,056 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 2 2003
* 2004/0057,991 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 10 2003
8,658,205 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 0 2011
 
GEORGIA-PACIFIC CHEMICALS LLC (2)
9,163,169 Adhesive compositions having a reduced cure time and methods for making and using same 0 2013
8,674,019 Composite products made with lewis acid catalyzed binder compositions that include tannins and multifunctional aldehydes 0 2013
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2019
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00